---
title: "DASH SARS-CoV-2 & Flu A/B Test Model/Catalog Number: SG-0006 combination COVI... — FDA record Z-2274-2025 | Is It on Recall"
description: "Due to manufacturing error, assay test may result in missed diagnosis or delay of treatment. (Potential false negative result)"
url: https://isitonrecall.com/recall/fda-device-z-2274-2025-dash-sars-cov-2-flu-a-b-test-model-catalog-number-sg-0006-combination-covid-19-and-flu-test-each-das/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA device enforcement

# DASH SARS-CoV-2 & Flu A/B Test Model/Catalog Number: SG-0006 combination COVID-19 and Flu test. Each DASH SARS-CoV-2 ... — FDA record Z-2274-2025

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Jun 25, 2025. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: DASH SARS-CoV-2 & Flu A/B Test Model/Catalog Number: SG-0006 combination COVID-19 and Flu test. Each DASH SARS-CoV-2 & Flu A/B Test is individually pouched and labeled. The tests are provided to users in quantities of 10 per kit. Used on the DASH instrument.
- **Reason**: Due to manufacturing error, assay test may result in missed diagnosis or delay of treatment. (Potential false negative result)
- **Classification**: Class II
- **Recalling firm**: Nuclein LLC
- **Quantity**: 710 units
- **Agency-reported status**: Ongoing
- **Source record identifier**: Z-2274-2025

[Open the official record](https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-2274-2025%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot Code: Lot: BB02 UDI: (01)00850063063036(17)260220(10)BB02 Expiration Date: 20 Feb. 2026 Lot Code: Lot: BB03 UDI: (01)00850063063036(17)260220(10)BB03 Expiration Date: 20 Feb. 2026 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

US distribution to: Florida, New York, Texas, and West Virginia

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [Florida](https://isitonrecall.com/state/florida/)
- [New York](https://isitonrecall.com/state/new-york/)
- [Texas](https://isitonrecall.com/state/texas/)
- [West Virginia](https://isitonrecall.com/state/west-virginia/)

## Dates in the source

- **Report date**: Aug 13, 2025
- **Recall initiation date**: Jun 25, 2025
- **Center classification date**: Aug 6, 2025

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-2274-2025%22)

## Related records

[Medical devices records](https://isitonrecall.com/category/medical-devices/) [Nuclein LLC records](https://isitonrecall.com/brand/nuclein-llc/)